Statins and the risk of dementia

Lancet

Volumn 356, Issue 9242, 2000, Pages 1627-1631

  Jick, H ^a   Zornberg, G L ^a,c   Jick, S S ^a   Seshadri, S ^a   Drachman, D A ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEMENTIA; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; UNITED KINGDOM;

EID: 0034638746     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03155-X     Document Type: Article

References (34)

1. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life
2. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
3. New criteria for the diagnosis of vascular dementia: Do we know enough yet?
4. Fronto-temporal dementia: Nosology, neuropsychology, and neuropathology
5. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
6. Degenerative dementias
7. Genetic determinants of Alzheimer disease
8. Inheritance of frontotemporal dementia
9. Association of apolipoprotein E type 4 allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
10. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study
11. Brain infarction and the clinical expression of Alzheimer disease. The Nun study
12. The role of cholesterol in the biosynthesis of beta-amyloid
13. Brain microvascular changes in Alzheimer's disease and other dementias
14. Role of the low-density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer disease
15. Cerebrovascular pathology in Alzheimer's disease: Cause, effect, or epiphenomenon?
16. Use of the UK General Practice Research Database for pharmacoepidemiology
17. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom
18. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease
19. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group
20. Regular aspirin intake and acute myocardial infarction
21. Multivitamin/folic acid supplementation in the earliest weeks of pregnancy reduces the prevalence of neural tube defects
22. Principles of epidemiologic research on adverse and beneficial drug effects
23. Drug treatment of lipid disorders
24. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study
25. Serum total cholesterol, apolipoprotein E4 allele, and Alzheimer's disease
26. HMGCoA reductase inhibitors (statins; a promising approach to stroke prevention
27. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
28. Low-density lipoprotein-independent effects of statins
29. Clinical studies of cerebral blood flow in Alzheimer's disease
30. Association between Alzheimer's disease and the NOS3 gene
31. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: Relevance to cerebral vasculopathy and neurodegeneration
32. The epidemiology of dementia among the elderly: Experience in a community-based registry
33. Decreased prevalence of Alzheimer's disease associated with 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors